By vgreene, 5 September, 2017 If pt experiences possible AE, advise stopping meds immediately and contacting HCP; do not wait until next clinic visit
By vgreene, 5 September, 2017 Clinical monitoring: Arrange for monthly pt visit; assess for compliance, s/sx of TB dz, and/or adverse effects, esp hepatitis (jaundice, loss of appetite, fatigue, and/or muscle/joint aches)
By vgreene, 5 September, 2017 Address barriers13-15 to pt adherence; recognize and address episodes of nonadherence ASAP. Adopt techniques for improvement16
By vgreene, 5 September, 2017 Use DOT in pts on intermittent dosing regimen, incl pts at esp high risk for TB dz who might be at risk of nonadherence
By vgreene, 5 September, 2017 Choose LTBI tx regimen based on drug susceptibility results of presumed source case (if known), coexisting medical illness, and potential for drug-drug interactions;1 if test for TB infxn negative, consider tx if HIV-infected pt had recent exposure to inf
By vgreene, 5 September, 2017 Choose LTBI tx regimen based on drug susceptibility results of presumed source case (if known), coexisting medical illness, and potential for drug-drug interactions:
